(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-24 View latest technical analysis
10 day averaged volume of Cue Biopharma is 319640
Date | Daily Closing Price | Open | High | Low | Volume |
24 Fri Jan 2025 | 1.49 | 1.40 | 1.49 | 1.36 | 1.213 times |
23 Thu Jan 2025 | 1.39 | 1.24 | 1.41 | 1.21 | 1.622 times |
22 Wed Jan 2025 | 1.21 | 1.19 | 1.22 | 1.11 | 1.443 times |
21 Tue Jan 2025 | 1.21 | 1.33 | 1.33 | 1.17 | 1.162 times |
17 Fri Jan 2025 | 1.31 | 1.30 | 1.32 | 1.22 | 0.631 times |
17 Fri Jan 2025 | 1.31 | 1.30 | 1.32 | 1.22 | 0.631 times |
16 Thu Jan 2025 | 1.28 | 1.31 | 1.36 | 1.21 | 1.13 times |
15 Wed Jan 2025 | 1.30 | 1.23 | 1.36 | 1.23 | 0.433 times |
14 Tue Jan 2025 | 1.22 | 1.33 | 1.37 | 1.20 | 1.27 times |
13 Mon Jan 2025 | 1.34 | 1.47 | 1.50 | 1.25 | 1.326 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 1.5 as stoploss in an intra day sell trade for a target of 1.32. However, stock will show a bullish move above 1.5.
Share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Target | 0.45 |
Downside Target | 0.68 |
Downside Target | 0.77 |
Downside Target | 0.92 |
Downside Target | 1.01 |
Downside Target | 1.11 |
Downside Target | 1.20 |
Downside Target | 1.32 |
Downside Target | 1.39 |
Downside Target | 1.49 |
Upside Target | 1.60 |
Upside Target | 1.75 |
Upside Target | 1.95 |
Upside Target | 1.99 |
Intraday share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Intraday Target | 1.24 |
Downside Intraday Target | 0.98 |
Upside Intraday Target | 1.62 |
Upside Intraday Target | 1.74 |
Downside Intraday Target | 1.36 |
Weekly technical analysis of Cue Biopharma (CUE)
Date | Weekly Closing Price | Open | High | Low | Volume |
24 Fri Jan 2025 | 1.49 | 1.33 | 1.49 | 1.11 | 8.625 times |
17 Fri Jan 2025 | 1.31 | 1.30 | 1.32 | 1.22 | 0.132 times |
17 Fri Jan 2025 | 1.31 | 1.47 | 1.50 | 1.20 | 5.46 times |
10 Fri Jan 2025 | 1.51 | 1.57 | 1.60 | 1.41 | 0.173 times |
08 Wed Jan 2025 | 1.45 | 1.45 | 1.75 | 1.39 | 0.614 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
Date | Monthly Closing Price | Open | High | Low | Volume |
24 Fri Jan 2025 | 1.49 | 1.09 | 1.75 | 1.03 | 1.396 times |
31 Tue Dec 2024 | 1.09 | 1.11 | 1.23 | 0.92 | 0.395 times |
26 Tue Nov 2024 | 1.09 | 1.65 | 1.99 | 1.01 | 0.495 times |
31 Thu Oct 2024 | 1.61 | 0.77 | 1.95 | 0.68 | 2.852 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.31 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.31 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.